[1]
“Metabolic fate of an antihyperuricemic peptide, Tyr-Leu-Asp-AsnTyr (YLDNY), upon ingestion in rats”, JFB, vol. 32, Dec. 2025, doi: 10.26599/JFB.2025.95032429.